Motivation: Oligonucleotide microarrays allow the genotyping of thousands of
Introduction
Oligonucleotide microarrays have been widely used to generate data for gene expression analysis (Lipschutz et al. 2000, Li and Wong 2001) . This technique has also been used to detect genetic variations of single-nucleotide-polymorphisms (SNPs) (Chee et al. 1996; Wang et al. 1998; Cargill et al. 1999) and to link SNPs to complex human diseases and drug susceptibilities (Hacia et al. 1999; Halushka et al. 1999) . Recently, oligonucleotide-based SNP arrays (HuSNP, Affymetrix 2000) containing 1494 human SNP markers have been used to identify loss-ofheterozygosity (LOH) of chromosomal regions based on paired normal and tumor samples from the same patient (Mei, R. et al. 2000; Lindblad-Toh et al. 2000; Schubert, E. L. et al. 2001 ).
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Affymetrix genotyping software analyzes the scanned image data of SNP arrays and generates SNP calls (Cutler et al. 2001) . The SNP calls of paired normal and tumor samples can then be combined to make LOH calls in dChipSNP (Figure 1 ).The existing methods in the literature for analyzing such LOH data are largely exploratory. In this paper, we present the quantitative methods and software specifically developed to analyze SNP-array-based LOH data, which include automated reading SNP calls from SNP call text files, pooling SNP array replicates, making LOH calls, making statistical inference for identifying shared LOH regions, and using LOH profiles for sample clustering.
In this paper we use the dataset in Lieberfarb et al. (2003) 
System and Methods dChipSNP software module
We develop a dChipSNP module based on the dChip software (Li and Wong 2001) to perform the aforementioned SNP-array-based LOH analysis. The HuSNP arrays have a similar format as oligonucleotide expression arrays, thus the existing functions in dChip such as "CEL Image View", "PM/MM Data View" are immediately available for HuSNP array analysis. After dChipSNP reads in HuSNP CEL files and the corresponding SNP call files, the array images and probe intensity data for individual SNPs can be visualized. Then the normal and tumor SNP calls are combined to make LOH calls as described in Table 1 . If sample replicates exist, the replicate SNP calls are pooled by the "Majority-Voting" scheme before making LOH calls (described in the "Pooling replicate arrays and making LOH calls" section).
In the dChipSNP "Chromosome View", users can choose to display the LOH calls (Figure 2 ), inferred LOH calls ( Figure 3 , described in the "Inferring Non-informative markers" section), or the original SNP calls. One may also enlarge a chromosomal region with shared LOH events to see the genes located in this region. Moreover, users may search a particular gene and examine whether some tumors have LOH in the nearby regions. The software and the manual can be obtained at http://biosun1.harvard.edu/complab/dchip/snp/.
Significance curve for shared LOH regions
After obtaining and visualizing LOH calls, we are often interested in defining the regions of LOH loss shared by multiple tumors because such regions are likely to contain tumor-suppressor genes. But this is typically done by simple methods such as visualization. Here we use permutation methods to answer the following questions:
where are the significant shared LOH regions, and how likely is an observed shared LOH region due to chance? The resulting p-value curves are displayed next to the LOH data to help investigators locate interesting shared LOH regions (Figure 2 ).
Specifically, for a particular chromosomal region, we define a score for each individual to quantify the region's likelihood of being "Loss". The scores of all individuals are then summed up to give a summary score for this chromosomal region. Suppose all the observed LOH events are due to call errors and thus are not cancer-related, then the paired normal and tumor samples are conceptually indistinguishable, and the observed differences between them represent the background noise from which we would like to distinguish the real LOH events. Therefore, we can simulate the background noise by permuting the paired normal and tumor samples. Specifically, for each individual, we randomly assign one of the paired samples as the tumor sample and treat the other as the normal. We then compare the LOH events in the original data with the LOH events in a large number of such simulated data to assess the statistical significance of the former. This permutation method can be applied for any reasonable scores, and we propose two scoring methods here.
A. Permutation using simple scores 5 For a SNP marker at the chromosomal position t-megabases, we define 1 ) ( = t C i for the i th individual if "Loss" is observed, -1 if the normal sample has a homozygous SNP call but the tumor sample has a heterozygous SNP call (this is most likely due to measurement error), and 0 if "Retention" or "Non-informative" is observed. We also
if this SNP is "Non-informative" and 1 otherwise. LOH NO_With
, where L is the length of the chromosome in megabase and N is the number of individuals, we consider a summary
. The i th summand in ) (x R can be viewed as the proportion of "Loss" events among all informative markers in this region for the i th individual, with penalty given to measurement errors and intervening "Retention" markers. We use the proportion of "Loss" markers rather than the actual counts of "Loss" markers to partially alleviate the influence of different marker densities at different chromosomal regions.
Under the null hypothesis that there are no real "Loss" regions for the entire chromosome (all the observed "Loss"s are assumed to come from measurement error), one can generate the null distribution of R(x) by permuting the paired SNP samples and then obtain a simulated
From a large number of such permutations, we obtain the estimate for the null distribution of R(x) and the raw p-value of a specific region (x -b, x + b) , which is the proportion of the permuted R(x) that are equal or greater than the observed R(x).
We then use either the maxT procedure (Westfall and Young, 1993) or the false discovery rate (FDR) controlling procedure (Benjamini and Hochberg, 1995) to adjust the p-values for multiple testing. The maxT procedure is performed as following: for each permuted dataset we obtain
the maximum score among all the regions on the genome or a chromosome) and the adjusted p-value of a specific
that are greater than the observed R(x). The first curve on the right side of Figure 2 is the pvalue curve generated by applying the above method with maxT adjustment (the 6 maximum is taken over the whole genome). Here we use b = 7 megabases and discretize x by increments of 1 megabase. That is, for each chromosome, we move a window of 14 megabases in length from one end to the other in one megabase step.
Each window overlaps with several of its neighboring windows and therefore the pvalues for these overlapping windows are positively correlated. The window size parameter b can be adjusted in the dChipSNP software to tune to datasets using particular tissues or arrays. The significant region of shared LOH shown in Figure 2 harbors the known PTEN tumor suppressor gene, and we discuss more of its biological implication elsewhere (Lieberfarb et al. 2003) . We also use the raw pvalues and the FDR controlling procedure to find the p-value threshold that corresponds to the nominal FDR. However, in our application this procedure is conservative in that it controls FDR at a level lower than the nominal level because , where i z (or i z′ ) = 1 ("Loss"), -1 ("Retention") or 0 ("Non-informative"). In the above notations, the ones with smaller subscripts are closer to the center x.
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In the HMM, the prior probability of LOH "Loss" at position x is (Durbin et. al. 1998 ).
Under the null hypothesis, we hypothesize that there is no real LOH events within the region (x -b, x + b) for this patient, and the observed LOH events are due to measurement errors. The likelihood of the data under the null hypothesis can be calculated as a special case of the HMM with all real LOH status being "Retention".
The HMM-based score of region (x -b, x + b) for the i th individual is then defined as the log likelihood ratio 
is driven by a single individual, it is truncated if it is higher than a pre-specified cutoff.
Permutation can then be performed in the same manner as in the previous section. The second curve on the right side of Figure 2 shows the p-value curve using HMM scores. It identifies the same shared LOH region as the simple score method. For this dataset we find that these two scoring methods identify similar shared LOH regions across the whole genome.
Considering the sparseness of LOH events in the prostate cancer data, we also test the permutation method on an independent breast cancer data where LOH events occur much more frequently (Wang et al. 2003) . The p-value curve for all chromosomes generated by using the simple score method is shown in Figure 3 . The curve is able to capture the regions where LOH events occur across multiple tumors, and therefore it can help investigators to focus on regions that are most likely to be really involved in the underlying biological process of tumor formation. In addition, filtering out nonsignificant regions improves the result of sample clustering by reducing the noises in the data, which is discussed in the next section.
Sample clustering based on significant LOH regions
Researchers are often interested in the co-occurrence of LOH events, or subclasses of tumor samples harboring similar LOH events across the genome. To this end, we applied the hierarchical clustering algorithm (Eisen et al. 1998) to tumor samples using LOH data of one chromosome or all chromosomes. We find that when using the data of all the chromosomal regions for clustering, the result tends to be driven by the "Retention" patterns in the non-significant regions. So we perform hierarchical clustering using only the LOH data in the identified significant LOH regions. We make LOH call for each of the significant regions in each individual: an individual is classified as "Loss" if there are one or more "Loss" SNP markers in the region, "Retention" if there is no "Loss" SNP marker but one or more "Retention" SNP markers in the region, and "Non-informative" if all the SNP markers in the region are variables, and will be presented elsewhere (Wang et al. 2003) .
Pooling replicate arrays and making LOH calls
The We use three percentages to assess how pooling replicate helps the analysis and by what magnitude (see Table 2 legend). All percentages are computed using the data of all patients after applying the "Majority-Voting" method to normal and tumor samples. The three percentages when not using tumor replicates, using tumor duplicates or triplicates are shown in Table 2 . As we would have expected, using duplicates decreases percentages for I and II while increases percentage for III.
However for percentage II and III, triplicating tumor samples does not have as much improving effect as duplicating them.
After pooling replicates to make pooled, we use the rules in Table 1 to make LOH calls from the SNP calls of paired normal and tumor samples. These LOH calls are the main data used in the aforementioned analysis.
Inferring Non-informative markers
It is often useful to infer the true status of the "Non-informative" calls. Lindblad-Toh et al. (2000) adopted a simple extension method. The drawback of this method is that it does not consider the relative chromosomal positions of the SNP markers. We implement the "Nearest Neighbor" and "Regions with Same Boundary" methods in dChipSNP to infer the LOH status of one megabase apart pseudo markers along the whole chromosome. The "Nearest Neighbor" method infers the LOH status of a pseudo maker as the LOH status of its nearest informative real marker. For "Regions with Same Boundary" method, the LOH status of all pseudo markers bounded by two real markers with the same LOH status ("Loss" or "Retention") are inferred as the LOH status of its two boundaries, and is not inferred ("Non-informative") if they are not bounded in this way. The color intensities of inferred pseudo markers decline to the white color as their distances from the nearest real markers increase, so the credibility of the inferred LOH calls can be visualized (Figure 3) . We also specify an extension limit (10 megabases as the default) so that pseudo markers are not inferred if their distances to the closest informative real markers are larger than this distance.
Discussions
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In this paper, we developed several methods for SNP-array-based LOH data analysis:
pooling SNP calls from replicate arrays and making LOH calls, visualizing LOH data, identifying shared LOH regions by statistical significance, clustering samples based on the identified shared LOH regions, and correlating LOH-based sample clusters with clinical variables. The next generation of Affymetrix SNP array consists of much denser 11,500 SNP markers and they have higher heterozygosity rate on average. We have found that most methods presented here can be readily applied to the data generated by the new SNP arrays.
There are many directions deserving further studies. Firstly, our two methods for identifying shared LOH regions do not use the probe level intensity data ( Figure 1 ). This is part of the reason why the more sophisticated HMM score method does not render a superior result over the simple score method. An HMM-type model on the probe level data may make better use of the information in data and give better result.
Secondly, LOH-based sample clustering is unsupervised, and as the data accumulate we may develop supervised classification method to predict tumor subtypes or survival time based on LOH patterns, in a way similar to classification based on gene expression data (Golub et al. 1999 ). Thirdly, in many LOH studies, the tumor samples are not homogeneous but vary in a set of clinical behaviors. It will be useful to develop a statistical method that can automatically identify regions that exhibit different LOH patterns in different subgroups defined by clinical behaviors with adjustment for potential confounders. Lastly, sometimes in addition to SNP data, we may also have data generated by gene expression microarrays and comparative genomic hybridization (CGH) for the same set of samples. How to properly integrate all these related genomics data to identify chromosomal changes and gene regulations underlying diseases is an exciting and challenging problem. We will be actively working on these aspects and report the progress in future work. 
